Počet záznamov: 1
abiraterón acetát
SYS d000069501 LBL 00000cz--a2200181n--4500 005 20250606221749.8 008 160101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 $d BA006 065 $a D04.210.500.054.079.065 066 $a 01 $c 03 150 $a abiraterón acetát $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a 17-(3-pyridyl)-5,16-androstadién-3beta-acetát $2 slo 450 $w v $a Zytiga $2 slo 550 $7 sllk_us_auth*d000970 $Y Antineoplastic Agents $w P $a antineoplastiká 550 $7 sllk_us_auth*d065088 $Y Steroid Synthesis Inhibitors $w P $a inhibítory syntézy steroidov 550 $7 sllk_us_auth*d065607 $Y Cytochrome P-450 Enzyme Inhibitors $w P $a inhibítory cytochrómu P-450 665 $a 2016 (1994) $2 eng 680 9-
$i An androstene derivative that inhibits STEROID 17-ALPHA-HYDROXYLASE and is used as an ANTINEOPLASTIC AGENT in the treatment of metastatic castration-resistant PROSTATE CANCER. $2 eng 750 -2
$a Abiraterone Acetate $2 eng 980 $x M
Počet záznamov: 1